Practical dietary recommendations for the prevention andmanagement of nonalcoholic fatty liver disease in adults

Advances in Nutrition

Volumn 9, Issue 1, 2018, Pages 30-40

  George, Elena S ^a,b   Forsyth, Adrienne ^a   Itsiopoulos, Catherine ^a   Nicoll, Amanda J ^d   Ryan, Marno ^e   Sood, Siddharth ^f   Roberts, Stuart K ^c   Tierney, Audrey C ^a,b  

^a LA TROBE UNIVERSITY   (Australia)

^b The Alfred   (Australia)

^c Gastroenterology Department   (Australia)

^d EASTERN HEALTH   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f MELBOURNE HEALTH   (Australia)

Author keywords

Clinical guidelines; Diet; Dietary recommendations; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

FRUCTOSE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID;

ADMINISTRATION AND DOSAGE; ADULT; BODY WEIGHT LOSS; DIET THERAPY; DIETARY FIBER; DRINKING BEHAVIOR; FAT INTAKE; HEALTHY DIET; HUMAN; MEDITERRANEAN DIET; NONALCOHOLIC FATTY LIVER;

ADULT; ALCOHOL DRINKING; DIET, MEDITERRANEAN; DIETARY FATS; DIETARY FIBER; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FRUCTOSE; HEALTHY DIET; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION THERAPY; WEIGHT LOSS;

EID: 85041701478     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.1093/advances/nmx007     Document Type: Review

References (124)

1. Gastroenterology Society of Australia. The Economic Cost and Health Burden of Liver Diseases in Australia. Sydney, Australia, The Gastroenterological Society of Australia/Australian Liver Association; 2013
2. Bellentani S, Scaglioni F,MarinoM, Bedogni G. Epidemiology of nonalcoholic fatty liver disease. Dig Dis 2010;28:155-61
3. Zoppini G, Fedeli U, Gennaro N, Saugo M, Targher G, Bonora E. Mortality from chronic liver diseases in diabetes. Am J Gastroenterol 2014;109:1020-5
4. McCarthy EM, Rinella ME. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J Acad Nutr Diet 2012;112:401-9
5. Schulz PO, Ferreira FG, Nascimento MdFA, Vieira A, Ribeiro MA, David AI, Szutan LA. Association of nonalcoholic fatty liver disease and liver cancer.World J Gastroenterol 2015;21:913-8
6. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23
7. LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh K-L, Hamid SS, Isakov V, Lizarzabal M, Peñaranda MM. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014;48:467-73
8. Marchesini G, Petta S, Grave RD. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice. Hepatology 2016;63:2032-43
9. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Oren R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007;47:711-7
10. Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, Kawamura M, Ebihara K, Onji M. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 2007;23:46-52
11. Caporaso N, Morisco F, Camera S, Graziani G, Donnarumma L, Ritieni A. Dietary approach in the prevention and treatment of NAFLD. Front Biosci (Landmark Ed) 2011;17:2259-68
12. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-31
13. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr 2014;17: 2769-82
14. Mediterranean-style diet counters metabolic syndrome. Tufts University Health & Nutrition Letter 2011;29(6):6
15. Esposito K, Giugliano D. Mediterranean diet and the metabolic syndrome: the end of the beginning. Metab 2010;8:197-200
16. Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, Fraser G, Kesler S, Levin SM, Lucey B. Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiology of Aging 2014;35:S74-S78
17. Opie R, Itsiopoulos C, Parletta N, Sanchez-Villegas A, Akbaraly T, Ruusunen A, Jacka F. Dietary recommendations for the prevention of depression. Nutr Neurosci 2016:1-11
18. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL.Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288(2):E462-E8
19. Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease.World Journal of Gastroenterology:WJG 2014;20(23):7392
20. Greer N, Mosser G, Logan G, Halaas GW. A practical approach to evidence grading. Jt Comm J Qual Improv 2000;26:700-12
21. Higgins JP, Altman DG, Gøtzsche PC, Juni P, Moher D, Oxman AD. Cochrane Bias Methods Group; Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928
22. NHMRC. NHMRC Levels of Evidence and Grades for Recommendations for Developers of Guidelines. Canberra, ACT: National Health and Medical Research Council, Commonwealth of Australia; 2009
23. Ebell MH, Siweks J, Weiss BD, Woolf SH, Susman J, Ewigman B. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract 2004;17:59-67
24. Schünemann H BJ, Guyatt G, Oxman A, editors. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach; updated 2013
25. PEN. Evidence Grading Checklist 2014 [cited 2016 Jun 10]
26. Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D, Fragopoulou E, Zafiropoulou R, Manios Y, Papatheodoridis G. Adherence to theMediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014;33:678-83
27. Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, O'Dea K, Desmond PV, Johnson NA,Wilson AM. TheMediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013;59:138-43
28. Gelli C, Tarocchi M, Abenavoli L, Di Renzo L, Galli A, De Lorenzo A. Effect of a counseling-supported treatment with theMediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.World J Gastroenterol 2017;23:3150
29. Trovato FM, Catalano D, Martines GF, Pace P, Trovato GM. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions. Clin Nutr 2015;34: 86-8
30. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008;48:993-9
31. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, Grosovski M. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008;22(10):811-6
32. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009;51:918-24
33. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier K-P, Bischoff SC, Bergheim I. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;138:1452-5
34. Chiu S, Sievenpiper J,De Souza R, CozmaA,Mirrahimi A, Carleton A, Ha V, Di Buono M, Jenkins A, Leiter L. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J ClinNutr 2014;68:416-23
35. Georgoulis M, Kontogianni MD, Margariti A, Tiniakos D, Fragopoulou E, Zafiropoulou R, Papatheodoridis G. Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease. J Hum Nutr Diet 2015;28:409-15
36. Allard JP, Aghdassi E,Mohammed S, RamanM, Avand G, Arendt BM, Jalali P,Kandasamy T, PrayitnoN, Sherman M.Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 2008;48:300-7
37. Oya J, Nakagami T, Sasaki S, Jimba S, Murakami K, Kasahara T, Wasada T, Sekiguchi H, Hasegawa M, Endo Y. Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. Eur J Clin Nutr 2010;64:1179-85
38. Lei S, LiuZW, YunL,CaiG, ZhangH, SongLJ,HuangCY,MingL. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci 2012;25:383-91
39. Kani AH, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: a parallel randomized trial. Nutrition 2014;30:814-21
40. Trovato FM, Catalano D, Martines GF, Pace P, Trovato GM. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions. Clin Nutr 2015;34:86-8
41. Roerecke M, Nanau R, Rehm J, Neuman M. Ethnicity matters: a systematic review and meta-analysis of the non-linear relationship between alcohol consumption and prevalence and incidence of hepatic steatosis. EBioMedicine 2016;8:317-30
42. Cotrim HP, Freitas LA, Alves E, Almeida A, May DS, Caldwell S. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur J Gastroenterol Hepatol 2009;21:969-72
43. Ekstedt M, Franzen LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, Kechagias S. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 2009;44:366-74
44. Ascha MS, Hanouneh IA, Lopez R, Tamimi TAR, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010;51:1972-8
45. Assy N, Nassar F, Nasser G, Grosovski M. Olive oil consumption and non-alcoholic fatty liver disease.World J Gastroenterol 2009;15:1809-15
46. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006;26:856-63
47. ParkerHM, JohnsonNA, BurdonCA,CohnJS, O'ConnorHT,George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012;56:944-51
48. Visioli F,Galli C. Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr 2002;42:209-21
49. Jensen MK, Koh-Banerjee P, Franz M, Sampson L,Grønbæk M, Rimm EB. Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation. AmJ Clin Nutr 2006;83:275-83
50. Wirström T, Hilding A, Gu HF, östenson C-G, Björklund A. Consumption of whole grain reduces risk of deteriorating glucose tolerance, including progression to prediabetes. Am J Clin Nutr 2013;97:179-87
51. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 2012;142:1304-13
52. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of mediterranean diet on metabolic syndrome and its components a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011;57:1299-313
53. Bazzano LA, He J, Ogden LG, LoriaC,Vupputuri S,Myers L, Whelton PK. Legume consumption and risk of coronary heart disease in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001;161:2573-8
54. Nöthlings U, Schulze MB, Weikert C, Boeing H, van der Schouw YT, Bamia C, Benetou V, Lagiou P, Krogh V, Beulens JWJ, et al. Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population. J Nutr 2008;138:775-81
55. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindström T, Nystrom FH, Group FFS. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 2008;57:649-54
56. Marchesini G, Ridolfi V, Nepoti V. Hepatotoxicity of fast food? Gut 2008;57:568-70
57. Pereira MA, Kartashov AI, Ebbeling CB, Van Horn L, Slattery ML, Jacobs DR, Ludwig DS. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 2005;365(9453):36-42
58. Simopoulos AP, Sidossis L.What is so special about the traditional diet of Greece. Mediterranean Diets.World Rev Nutr Diet 2000;87:24-42
59. Darmadi-Blackberry I, Wahlqvist ML, Kouris-Blazos A, Steen B, Lukito W, Horie Y, Horie K. Legumes: the most important dietary predictor of survival in older people of different ethnicities. Asia Pac J Clin Nutr 2004;13:217-20
60. Azzini E, Polito A, Fumagalli A, Intorre F, Venneria E, Durazzo A, Zaccaria M, Ciarapica D, Foddai MS, Mauro B. Mediterranean diet effect: an Italian picture. Nutrition Journal 2011;10:1
61. Jones JL,ComperatoreM, Barona J, CalleMC, Andersen C, McIntosh M, Najm W, Lerman RH, Fernandez ML. A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome. Metabolism 2012;61:366-72
62. Albenberg LG, Wu GD. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 2014;146:1564-72
63. Parnell JA, Raman M, Rioux KP, Reimer RA. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver International 2012;32:701-11
64. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56:365-79
65. Patterson E, Wall R, Fitzgerals GF, Ross RP, Stanton C. Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab 2012;2012:16
66. Sacks FM. Dietary fat, the Mediterranean diet, and health: reports from scientific exchanges, 1998 and 2000. Introduction. Am J Med 2002;113(Suppl 9B):1S-4S
67. Soriguer F, Morcillo S, Cardona F, Rojo-Martinez G, de la Cruz Almaraz M, Ruiz de Adana Mde L, Olveira G, Tinahones F, Esteva I. Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J Nutr 2006;136:2325-30
68. Williams C. Beneficial nutritional properties of olive oil: implications for postprandial lipoproteins and factor VII. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2001;11(4 Suppl):51-6
69. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010;7:e1000252
70. Michas G, Micha R, Zampelas A. Dietary fats and cardiovascular disease: putting together the pieces of a complicated puzzle. Atherosclerosis 2014;234:320-8
71. Vannice G, Rasmussen H. Position of the academy of nutrition and dietetics: dietary fatty acids for healthy adults. J Acad Nutr Dietet 2014;114:136-53
72. Wang D, Wei Y, Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006;147:943-51
73. Kennedy A, Martinez K, Chuang C-C, LaPoint K, McIntosh M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr 2009;139:1-4
74. Hellerstein MK, Schwarz J-M,NeeseRA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996;16:523-57
75. Goran MI, Walker R, Allayee H. Genetic-related and carbohydraterelated factors affecting liver fat accumulation. Curr Opin Clin Nutr Metab Care 2012;15:392
76. Jin R, Welsh JA, Le N-A, Holzberg J, Sharma P, Martin DR, Vos MB. Dietary fructose reduction improves markers of cardiovascular disease risk inHispanic-American adolescents withNAFLD.Nutrients 2014;6:3187-201
77. Who J, Consultation FE. Diet, nutrition and the prevention of chronic diseases.World Health Organ Tech Rep Ser 2003;916(i-viii)
78. Bach-Faig A, Berry EM, Lairon D, Reguant J, Trichopoulou A,Dernini S, Medina FX, Battino M, Belahsen R, Miranda G. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr 2011;14:2274-84
79. HernándezRuizA,García-VillanovaB,GuerraHernándezEJ, Amiano P, Azpiri M, Molina Montes E. Description of indexes based on the adherence to the Mediterranean Dietary Pattern: a review. Nutr Hosp 2015;32(5):1872-84
80. Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H. Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr 2016;67:1024-9
81. RazaviZadeM,TelkabadiMH,Bahmani F, Salehi B, Farshbaf S, Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int 2016;36:563-71
82. Schultz A, Neil D, Aguila MB, Mandarim-de-Lacerda CA. Hepatic adverse effects of fructose consumption independent of overweight/obesity. Int J Mol Sci 2013;14:21873-86
83. Lichtenstein AH. Thematic review series: patient-oriented research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns. J Lipid Res 2006;47:1661-7
84. Hunter JE, Zhang J, Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 2010;91:46-63
85. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 2011;93:950-62
86. Elmadfa I, Kornsteiner M. Fats and fatty acid requirements for adults. Ann Nutr Metab 2009;55:56-75
87. Smit LA, Mozaffarian D, Willett W. Review of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann Nutr Metab 2009;55:44-55
88. del Gobbo LC. Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA 2016;176:1155-66
89. Kastorini C-M, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011;57:1299-313
90. Bloomfield HE, Koeller E, Greer N, MacDonald R, Kane R, Wilt TJ. Effects on health outcomes of aMediterranean diet with no restriction on fat intake: a systematic review and meta-analysis. Ann Intern Med 2016;165:491-500
91. Godos J, Zappala G, Bernardini S, Giambini I, Bes-Rastrollo M, Martinez-Gonzalez M. Adherence to the Mediterranean diet is inversely associated with metabolic syndrome occurrence: a metaanalysis of observational studies. Int J Food Sc Nutr 2016;68:1-11
92. Liyanage T, Ninomiya T, Wang A, Neal B, Jun M, Wong MG, Jardine M, Hillis GS, Perkovic V. Effects of the Mediterranean diet on cardiovascular outcomes-a systematic reviewandmeta-analysis. PloS One 2016;11:e0159252
93. Gillingham LG, Harris-Janz S, Jones PJH. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 2011;46:209-28
94. Ros E. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 2003;78:617S-25S
95. Kris-Etherton PM, Committee N. Monounsaturated fatty acids and risk of cardiovascular disease. Circulation 1999;100:1253-8
96. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998;67:577S-82S
97. Aguilera C, Mesa M, Ramirez-Tortosa M, Nestares M, Ros E, Gil A. Sunflower oil does not protect against LDL oxidation as virgin olive oil does in patients with peripheral vascular disease. Clin Nutr 2004;23:673-81
98. Harper CR, Edwards MC, Jacobson TA. Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjects. J Nutr 2006;136:2844-8
99. McKeown NM, Hruby A, Saltzman E, Choumenkovitch SF, Jacques PF. Weighing in on whole grains: a review of evidence linking whole grains to body weight. Public Health Nutr 2015;1:6
100. NHMRC. Australian Guidelines to Reduce Health Risks from Drinking Alcohol. Canberra, Australia: National Health and Medical Research Council; 2009
101. National Institutes of Health. US Department of Health and Human Services [Internet]. Health NIo; 2016 [cited 2017 Aug 26]. Available from: https://pubs.niaaa.nih.gov/publications/ rethinkingdrinking/rethinking_drinking.pdf
102. Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 2011;300: E122-33
103. Yamauchi R, Kobayashi M, Matsuda Y, Ojika M, Shigeoka S, Yamamoto Y, Tou Y, Inoue T, Katagiri T,Murai A. Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. J Agric Food Chem 2010;58:5597-603
104. Fukushima Y,KasugaM,Nakao K, Shimomura I,Matsuzawa Y. Effects of coffee on inflammatory cytokine gene expression in mice fed highfat diets. J Agric Food Chem 2009;57:11100-5
105. Vitaglione P, Morisco F, Mazzone G, Amoruso DC, Ribecco MT, Romano A, Fogliano V, Caporaso N, D'Argenio G. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.Hepatology 2010;52:1652-61
106. Yesil A, Yilmaz Y. Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38:1038-44
107. Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M, Kumagae S-I,Hirai Y, Jalaldin A, SatohA.Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 2007;76:383-9
108. Anty R, Marjoux S, Iannelli A, Patouraux S, Schneck A-S, Bonnafous S, Gire C, Amzolini A, Ben-Amor I, Saint-Paul M-C. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 2012;57:1090-6
109. Catalano D, Martines GF, Tonzuso A, Pirri C, Trovato FM, Trovato GM. Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 2010;55:3200-6
110. Gutiérrez-Grobe Y, Chávez-Tapia N, Sánchez-Valle V, Gavilanes-Espinar JG, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. Ann Hepatol 2012;11:350-5
111. Birerdinc A, Stepanova M, Pawloski L, Younossi Z. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012;35:76-82
112. Molloy JW, Calcagno CJ,Williams CD, Jones FJ, Torres DM, Harrison SA. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012;55:429-36
113. Zelber-Sagi S, Salomone F, Webb M, Lotan R, Yeshua H, Halpern Z, Santo E, Oren R, Shibolet O. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res 2015;165:428-36
114. Saab S,MallamD, Cox GA, TongMJ. Impact of coffee on liver diseases: a systematic review. Liver Int 2014;34:495-504
115. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M. Effects of caffeine on human health. Food Addit Contam 2003;20: 1-30
116. Heckman MA, Weil J, Mejia D, Gonzalez E. Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010;75: R77-87
117. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, et al. Primary prevention of cardiovascular diseasewith aMediterranean diet.NEngl J Med 2013;368:1279-90
118. Itsiopoulos C, Brazionis L, Kaimakamis M, Cameron M, Best JD, O'Dea K, Rowley K. Can theMediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study. Nutr Metab Cardiovasc Dis 2011;21:740-7
119. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to theMediterranean diet on health: an updated systematic review and meta-analysis. American Journal of Clin Nutr 2010;92:1189-96
120. Opie RS, Segal L, Jacka FN, Nicholls L, Dash S, Pizzinga J, Itsiopoulos C.Assessing healthy diet affordability in a cohortwithmajor depressive disorders. J Public Health Epidemiol 2015;7:159-69
121. Papamiltiadous ES, Roberts SK, Nicoll AJ, Ryan MC, Itsiopoulos C, Salim A, Tierney AC. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol. BMC Gastroenterol 2016;16:1
122. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-5
123. Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Cartenì M, Nardone G. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2012;22:471-6
124. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505(7484):559-63